Latest Epidermal growth factor receptor Stories
A review in the December issue of the journal Archives of Pathology & Laboratory Medicine describes the current state of lung cancer care.
Researchers at The University of Texas MD Anderson Cancer Center have tracked down a cancer-promoting protein's pathway into the cell nucleus and discovered how, once there, it fires up a glucose metabolism pathway on which brain tumors thrive.
A more-sensitive method to analyze protein interactions has uncovered a new way that cancer cells may use the cell-surface molecule HER3 to drive tumor progression following treatment with HER1 and HER2 inhibitors.
“Getting under your skin” takes on a brave new meaning thanks to Northwestern University research that could transform gene regulation.
People with lung cancer who are treated with the drug Tarceva face a daunting uncertainty: although their tumors may initially shrink, it's not a question of whether their cancer will return—it's a question of when.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have conducted the first comprehensive census of human cells’ export workers.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.